Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Symptom relief is main take-away from either OTC or Rx DTC ads, advertiser notes.

This article was originally published in The Tan Sheet

Executive Summary

SYMPTOM RELIEF IS MAJOR TAKE-AWAY FROM EITHER OTC OR DTC Rx ADS, TRL Consumer Advertising President Shane Kennedy said during a presentation at the PharMillenium pharmaceutical congress in Stuart, Fla. Jan. 28-30. "What we've found through the course of ad testing and market research is that consumers recognize the difference in Rx and OTC brands, but when they are watching advertising and hearing communications, all they are interested in is symptom relief," Kennedy said. Consumers "are not really worried where [the medication] comes from, whether it's OTC or Rx, so from the communication standpoint, they are listening to all the messages when it comes to symptom relief."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel